Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-27

Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone [Phase 3]

View source ↗

Summary

This completed Phase 3 trial evaluated the efficacy and safety of insulin detemir added to oral hypoglycemic therapy in adults with type 2 diabetes inadequately…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED